HOME >> BIOLOGY >> NEWS
Controlling robots that search for Mars life

As part of ESA's ambitious, long-term Aurora exploration programme, ExoMars will search for traces of life on Mars. The mission requires entirely new technologies for self-controlled robots, built-in autonomy and cutting-edge visual terrain sensors.

The fourth decade of this century could see Europe participating in a manned mission to Mars in what would be one of humanity's grandest space expeditions ever. Aurora is ESA's programme aimed at the long-term robotic and human exploration of the Solar System, with Mars and the Moon as the main targets.

A human mission to the Red Planet would be a major, multi-year undertaking requiring fantastic, entirely new capabilities such as automated cargo vessels, prepositioned supplies and tools, and communication and navigation satellites in Mars orbit similar to Earth's current GPS systems. Scientists and engineers are already working on ESA's first robotic 'precursor' mission, ExoMars, due for launch around 2011.

ExoMars will explore the biological environment on Mars in preparation for further robotic and, later, human activity. Data from the mission will also provide invaluable input for broader studies of exobiology the search for life on other planets.

The main element of the mission is a wheeled, robotic rover vehicle, similar in concept to NASA's current Mars Rover mission, but having different scientific objectives and improved capabilities.

ExoMars: a wheeled rover delivered in a dramatic direct approach

The mission will likely consist of a carrier spacecraft, a descent module, some sort of landing system, and the surface rover, and the mission profile is likely to include a dramatic direct approach to Mars, with the carrier spacecraft discarded after the rover detaches itself for descent to the surface.

The rover will use solar arrays to generate electricity, and will travel over the rocky orange-red surface of Mars, transportin
'"/>

Contact: Jocelyne Landeau-Constantin
jocelyne.landeau-constantin@esa.int
49-06-151-2696
European Space Agency
11-Jul-2006


Page: 1 2 3 4

Related biology news :

1. Controlling algal blooms
2. Controlling the spread of invasive plants: a national effort one-day symposium, Aug. 30
3. Controlling wildlife trade key to preventing health crises, study says
4. Controlling protein diversity
5. Biomimetic Technologies project will create first soft-bodied robots
6. Of I robots go solar; new system could drastically reduce herbicide use
7. Underwater robots work together without human input
8. BACS breathes perception into robots
9. Talking robots, green buildings, and shockwave healing
10. Teams build robots that walk like humans
11. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Controlling robots that search for Mars life

(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: